SnagRx vs Wellmedr: Compounded GLP-1 Pricing, Shipping & Guarantees

Choosing between SnagRx vs Wellmedr comes down to whether you prioritise lower annual-plan pricing and named partner pharmacies (SnagRx) or a different starting price and stated lifetime locked pricing (Wellmedr). Early verdict: SnagRx advertises lower 12-month plan rates for compounded semaglutide and tirzepatide and names its clinician network and 503A pharmacies; Wellmedr advertises lifetime locked pricing and same-day review with free overnight shipping.

See SnagRx plans from $69/mo

Price and payment structure compared

Both providers publish monthly starting prices for compounded GLP-1s but with different promoted entry points and conditions. SnagRx lists semaglutide from $69/month and tirzepatide from $119/month as 12-month plan rates; month-to-month rates are higher at $99 and $149. Wellmedr lists semaglutide starting at $89/month on its 1-year plan and advertises promotional messages including a Labor Day sale and other limited offers that reference lower 12-month plan figures in captured landing content.

View Wellmedr plans starting at $89/mo

Price lock and dose-based pricing

Both brands claim price protections but with different emphases. SnagRx states the rate is locked flat at every dose and at renewal on its advertised plans; it highlights that many compounded programs re-price during titration and positions its flat pricing as a differentiator. Wellmedr advertises lifetime locked-in pricing and explicitly says no dose-based price increases.

Medications, compounding, and regulatory notes

Both SnagRx and Wellmedr offer compounded GLP-1 medications from licensed U.S. pharmacies. Each source captures the regulatory disclosure that compounded medications are not FDA-approved finished products and are not evaluated by FDA for safety, effectiveness, or quality. SnagRx repeatedly states its medications are compounded and names its US 503A partner pharmacies; Wellmedr also notes it offers compounded GLP-1s exclusively from licensed U.S. pharmacies.

Clinician review, pharmacy partners, and state coverage

SnagRx states its clinician network is OpenLoop Health, a network of US-licensed clinicians covering 48 states, and says clinician review typically occurs within five hours and orders ship next-day via UPS or FedEx. SnagRx names its four US 503A partner pharmacies in its captured evidence. Wellmedr highlights same-day review and free overnight shipping in its captured claims. Wellmedr does not supply captured details about the exact clinician network or the number of states covered in the supplied evidence; the captured content does warn that eligibility, pharmacy, and state coverage may change.

Check SnagRx clinician and pharmacy details

Five-point comparison table

Criteria	SnagRx	Wellmedr
Starting semaglutide price	$69/mo on 12-month plan (month-to-month $99)	$89/mo on 1-year plan (captured promotions vary)
Price lock	Rate locked flat at every dose and at renewal	Advertised lifetime locked-in pricing; no dose-based price increases
Medication type	Compounded semaglutide and tirzepatide from named US 503A pharmacies	Compounded GLP-1 medications from licensed U.S. pharmacies
Clinician and review speed	OpenLoop Health clinician network; review typically within 5 hours	Claims same-day review in captured landing content
Shipping	Next-day UPS/FedEx temperature-controlled shipping; free shipping claimed	Free overnight shipping and guaranteed on-time refills in captured claims
Guarantees and refunds	Full refund if prescription declined; mentions a 6-month weight-loss guarantee (terms apply)	Money-back guarantee claim: refund if no weight loss in 90 days in captured content

Guarantees, marketing, and program extras

SnagRx emphasizes low annual-plan pricing, a price lock across titration, and names its pharmacies and clinician partner. SnagRx also discloses that its assessment does not create a doctor-patient relationship and that OpenLoop clinicians retain prescribing decisions. Wellmedr promotes lifetime lock messaging, promotional sales in captured landing content, and a captured money-back guarantee tied to 90-day weight-loss language. Neither source supplies independent clinical outcome data specific to their programs beyond the captured marketing claims and general references to published GLP-1 research.

Compare SnagRx pricing and terms now

How they differ most

• Starting price on the advertised annual plan: SnagRx shows lower 12-month plan rates ($69 semaglutide; $119 tirzepatide) versus Wellmedr’s captured $89 starting figure.
• Disclosure of partners: SnagRx names its US 503A pharmacies and OpenLoop Health clinician network; Wellmedr does not supply named pharmacies in the captured evidence.
• Guarantees and refund framing: SnagRx notes a full refund if a prescription is declined and advertises a 6-month weight-loss guarantee subject to terms; Wellmedr’s captured content includes a 90-day money-back claim.
• Shipping and review timing: SnagRx captures typical clinician review within five hours and next-day shipping; Wellmedr captures same-day review and free overnight shipping claims.

Conclusion: SnagRx vs Wellmedr

SnagRx vs Wellmedr trade lower advertised 12-month plan prices and named partner disclosures (SnagRx) for a different advertised starting price and promotional guarantees (Wellmedr). Both offer compounded GLP-1 products and both include regulatory disclosures that compounded medications are not FDA-approved. Verify eligibility, state coverage, specific plan terms and clinician approval before enrolling because each provider’s captured materials include conditional language about clinician review and state or eligibility limits.

Choose SnagRx if you want lower advertised 12-month plan pricing, a stated price lock at every dose, named US 503A pharmacies and a stated OpenLoop Health clinician network. Choose Wellmedr if you prioritise the lifetime locked pricing messaging and the captured same-day review and overnight shipping claims, and if you prefer to confirm its promotional terms first.

View Wellmedr offers and terms